跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bucligen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bucligen
Approved
STANDARD
Bucligen
Azarias Pharmaceutical Laboratories Inc,
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c6cb07562e88c30b
Company
Azarias Pharmaceutical Laboratories Inc,
Type
Standard
Approval Details
Approval Id
c6cb07562e88c30b
Drug Approval Philippines Name
Bucligen
Product Name
Bucligen
Registration Number
DRP-5903-07
Brand Name
Bucligen
Generic Name
Vitamin B-Complex + Iron + Buclizine Hydrochloride
Dosage Form
Capsule
Dosage Strength
10mg/ 1.80mg/ 20mg/ 5mg/ 5mcg/ 80mg/ 25mg
Manufacturer
Azarias Pharmaceutical Laboratories Inc,
Distributor
EBA Generisch Trading Inc.
Issuance Date
24 December 2024
Expiry Date
23 December 2029
Pharmacologic Category
Multivitamins
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c6cb07562e88c30b
Type
Standard
Back to Philippines FDA Approvals